Portage Biotech (PRTG) Filings

6-K

PRTG Portage Biotech Inc

13 Mar 23

Current report (foreign)

6:16pm

6-K

PRTG Portage Biotech Inc

1 Mar 23

Current report (foreign)

4:30pm

6-K

PRTG Portage Biotech Inc

6 Jan 23

Current report (foreign)

4:49pm

6-K

PRTG Portage Biotech Inc

30 Nov 22

Current report (foreign)

9:08pm

6-K

PRTG Portage Biotech Inc

29 Nov 22

Current report (foreign)

4:58pm

6-K

PRTG Portage Biotech Inc

15 Nov 22

Current report (foreign)

4:43pm

6-K

PRTG Portage Biotech Inc

9 Nov 22

Portage Biotech Announces Clinical Trial Collaboration Agreement with Merck

4:01pm

6-K/A

PRTG Portage Biotech Inc

12 Oct 22

Financial Statements for the years ended Report of Independent Registered Public Accounting Firm

5:45pm

6-K

PRTG Portage Biotech Inc

7 Oct 22

Notice of Annual General Meeting

3:06pm

6-K

PRTG Portage Biotech Inc

22 Sep 22

Current report (foreign)

4:07pm

6-K

PRTG Portage Biotech Inc

14 Sep 22

Current report (foreign)

10:31am

6-K

PRTG Portage Biotech Inc

29 Aug 22

Current report (foreign)

4:00pm

6-K

PRTG Portage Biotech Inc

19 Aug 22

Current report (foreign)

10:54am

424B5

PRTG Portage Biotech Inc

19 Aug 22

Prospectus supplement for primary offering

10:52am

6-K

PRTG Portage Biotech Inc

1 Aug 22

Current report (foreign)

4:48pm

D

PRTG Portage Biotech Inc

29 Jul 22

$34.64M in equity, sold $34.64M, 4 investors

6:15pm

6-K

PRTG Portage Biotech Inc

19 Jul 22

Portage Biotech Acquires Outstanding Minority Interest of Invariant Natural Killer T cell (iNKT) Agonist Platform

9:01am

6-K

PRTG Portage Biotech Inc

8 Jul 22

Current report (foreign)

8:58am

6-K

PRTG Portage Biotech Inc

7 Jul 22

Portage Biotech Bolsters Pipeline with Acquisition of Four Candidates Targeting the Adenosine Pathway

8:30am